Literature DB >> 10205768

Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method.

A Hisaka1, Y Sugiyama.   

Abstract

A numerical calculation method for dispersion models was developed to analyze nonlinear and nonsteady hepatic elimination of substances. The finite difference method (FDM), a standard numerical calculation technique, was utilized to solve nonlinear partial differential equations of the dispersion model. Using this method, flexible application of the dispersion model becomes possible, because (i) nonlinear kinetics can be incorporated anywhere, (ii) the input function can be altered arbitrarily, and (iii) the number of compartments can be increased as needed. This method was implemented in a multipurpose nonlinear least-squares fitting computer program, Napp (Numeric Analysis Program for Pharmacokinetics). We simulated dilution curves for several nonlinear two-compartment hepatic models in which the saturable process is assumed in transport or metabolism, and investigated whether they could definitely be discriminated from each other. Preliminary analysis of the rat liver perfusion data of a cyclic pentapeptide, BQ-123, was performed by this method to demonstrate its applicability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10205768     DOI: 10.1023/a:1023294632129

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  39 in total

1.  Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; Y Aoyama; H Tanaka
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

2.  On the relation between extended forms of the sinusoidal perfusion and of the convection-dispersion models of hepatic elimination.

Authors:  L Bass; M S Roberts; P J Robinson
Journal:  J Theor Biol       Date:  1987-06-21       Impact factor: 2.691

3.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

4.  Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.

Authors:  A Rane; G R Wilkinson; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1977-02       Impact factor: 4.030

5.  Hepatic elimination--dispersion model.

Authors:  M S Roberts; M Rowland
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

6.  Hepatic elimination of flowing substrates: the distributed model.

Authors:  L Bass; P Robinson; A J Bracken
Journal:  J Theor Biol       Date:  1978-05-08       Impact factor: 2.691

7.  Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method.

Authors:  S C Tsao; Y Sugiyama; Y Sawada; S Nagase; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

8.  Enalaprilat handling by the kidney: barrier-limited cell entry.

Authors:  A J Schwab; I A de Lannoy; C A Goresky; K Poon; K S Pang
Journal:  Am J Physiol       Date:  1992-11

9.  Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver.

Authors:  M Yamazaki; H Suzuki; M Hanano; T Tokui; T Komai; Y Sugiyama
Journal:  Am J Physiol       Date:  1993-01

10.  Multispecificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles.

Authors:  B Zimmerli; J Valantinas; P J Meier
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

View more
  19 in total

1.  A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.

Authors:  R E Oliver; A F Jones; M Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Quantitative evaluation of capacity-limited hepatobiliary transport based on hepatocellular diffusion model by MULTI(FEM).

Authors:  M Higashimori; K Yamaoka; S Fujitani; T Nakagawa
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

3.  A novel hepatic-targeting system for therapeutic cytokines that delivers to the hepatic asialoglycoprotein receptor, but avoids receptor-mediated endocytosis.

Authors:  Haruya Sato; Yukio Kato; Eiko Hayasi; Tomoyuki Tabata; Manabu Suzuki; Yoshiyuki Takahara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

4.  A dispersion model for cellular signal transduction cascades.

Authors:  Murali Ramanathan
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

5.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

Review 6.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Analysis of nonlinear hepatic clearance of a cyclopentapeptide, BQ-123, with the multiple indicator dilution method using the dispersion model.

Authors:  A Hisaka; T Nakamura; Y Sugiyama
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

8.  Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam.

Authors:  Wataru Ochiai; Hiroko Kobayashi; Satoshi Kitaoka; Mayumi Kashiwada; Yuya Koyama; Saho Nakaishi; Tomomi Nagai; Masaki Aburada; Kiyoshi Sugiyama
Journal:  J Nat Med       Date:  2018-03-17       Impact factor: 2.343

9.  Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice.

Authors:  Yoshiyuki Shirasaka; Nora Lee; Weibin Zha; David Wagner; Joanne Wang
Journal:  Drug Metab Pharmacokinet       Date:  2016-04-30       Impact factor: 3.614

Review 10.  Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience.

Authors:  Karen S Blesch; Ronald Gieschke; Yuko Tsukamoto; Bruno G Reigner; Hans U Burger; Jean-Louis Steimer
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.